Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Tickers BIIB ESALY NEWS SHL
Tags Biotech Large Cap Health Care
From Benzinga
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Tickers BIIB ESALY LLY NEWS
Tags Benzinga LLY Market News
From Benzinga
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Tickers BIIB ESALY NEWS
Tags Biotech Large Cap BIIB
From Benzinga
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
Tickers BIIB ESALY
Tags ESALY Market News BIIB
From Motley Fool
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Tickers BIIB ESALF ESALY LLY
Tags Benzinga LLY Market News
From Benzinga
This Is Massive News for Eli Lilly Investors
Tickers BIIB ESALY LLY NVO
Tags Market News LLY NVO
From Motley Fool
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Tickers BIIB ESALY NEWS
Tags Biotech Large Cap BIIB
From Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
Tickers BIIB ESALF ESALY NEWS
Tags Market News Benzinga Biotech
From Benzinga
Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision
Tickers BIIB ESALY LLY NEWS
Tags Stories That Matter Movers ESALY
From Benzinga
Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says
Tickers BIIB ESALY NEWS NVS
Tags Briefs News Price Target
From Benzinga
Why Is Biogen Stock Trading Lower On Tuesday?
Tickers BIIB ESALY NEWS
Tags Market News Benzinga Large Cap
From Benzinga
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
Tickers BIIB DGX ESALY LH
Tags News ESALY DGX
From Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags ESALF Briefs News
From Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Tickers ACIU BIIB ESAIY ESALY
Tags Expert Ideas General Briefs
From Benzinga
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
Tickers BIIB ESALY
Tags Health Care BIIB Biotech
From Benzinga
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
Tickers BIIB ESALF ESALY LLY
Tags ESALF News Briefs
From Benzinga
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Tickers BIIB DGX ESALY LH
Tags Large Cap DGX Health Care Services
From Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
Tickers BIIB ESALF ESALY LLY
Tags Benzinga LLY Market News
From Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Tickers AA AAPL AMZN BIIB
Tags Market News AAPL Penny Stocks
From Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
Tickers BIIB ESALF ESALY
Tags Market News ESALF Benzinga
From Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
Tickers ESALF ESALY MRK
Tags Health Care Biotech Large Cap
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
Tickers ESALF ESALY MRK
Tags ESALF General ESALY
From Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Tickers BIIB ESALY RETA
Tags ESALY Market News RETA
From Motley Fool
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
Tickers BIIB ESALF ESALY
Tags Analyst Color Expert Ideas ESALF
From Benzinga
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
Tickers BIIB ESALY
Tags Market News Benzinga ESALY
From Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
Tickers AAPL ATVI BEP BIIB
Tags SPY Top Stories SFTBY
From Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
Tickers BIIB ESALF ESALY
Tags Biotech Health Care BIIB
From Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
Tickers BIIB ESALF ESALY
Tags Benzinga FDA Trading Ideas
From Benzinga
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
Tickers BIIB ESALY ILMN KDNY
Tags Adam Turnquist Market News ILMN
From Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags Market News Alzheimer’s Benzinga
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.